← FDA Drug Approvals (Drugs@FDA)
DICLOFENAC POTASSIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TARO · Approved 2024-06-14
Drug application
- FDA Application #
ANDA218011- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DICLOFENAC POTASSIUM
- Generic name
- DICLOFENAC POTASSIUM
- Active ingredients
- DICLOFENAC POTASSIUM
- Dosage form
- FOR SOLUTION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- TARO
- Manufacturer
- Taro Pharmaceuticals U.S.A., Inc.
- First approval
- 2024-06-14
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown